Research Papers:

Genetic variation of CXCR4 and risk of coronary artery disease: epidemiological study and functional validation of CRISPR/Cas9 system

Guo Runmin, Jiang Jiamei, Jing Zhiliang, Chen Yonghua, Shi Zhizhou, Tao GuiZhou and Liu Shuguang _

PDF  |  HTML  |  How to cite

Oncotarget. 2018; 9:14077-14083. https://doi.org/10.18632/oncotarget.23491

Metrics: PDF 1344 views  |   HTML 1867 views  |   ?  


Guo Runmin1, Jiang Jiamei1, Jing Zhiliang2, Chen Yonghua2, Shi Zhizhou3, Tao Guizhou4 and Liu Shuguang5

1Department of Cardiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, P.R. China

2Department of Pathology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, P.R. China

3Department of Endocrinology and Metabolism, Longgang District People’s Hospital, Shenzhen 518172, China

4The Third People’s Hospital of Dalian, Dalian, Liaoning 116091, P.R. China

5Department of Pathology, The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong 518033, P.R. China

Correspondence to:

Liu Shuguang, email: [email protected]

Keywords: coronary artery disease; variation; genetic; CXCR4

Received: June 23, 2017     Accepted: October 05, 2017     Epub: December 15, 2017     Published: March 06, 2018


Cardiovascular diseases (CVDs) remain the leading cause of death worldwide, while coronary artery disease (CAD) account for a large part of CVDs. Vascular CXCR4 could limit atherosclerosis by maintaining arterial integrity. Here, we conducted a population-based, case-control study to evaluate the associations of common genetic variation within the CXCR4 gene (rs2228014, rs117600832, rs2471859, and rs2322864) with CAD risk in a Chinese population. We found that CXCR4 rs2228014 was significantly associated with 1.29-fold increased risk of CAD (A vs G: OR = 1.29; 95% CI = 1.07–1.55; P = 0.007). The subjects with genotype AA (OR = 1.98; 95% CI = 1.03–3.81; P = 0.041) and AG (OR = 1.27; 95% CI = 1.02–1.58; P = 0.030) have higher risk of CAD, compared with those with genotype GG. Furthermore, both in the CAD patients with diabetes and those without diabetes, rs2228014 was significantly associated with increased risk of CAD (P < 0.05). Additionally, we also validated the significant association for rs2322864 (C vs T: OR = 1.20; 95% CI = 1.00–1.44; P = 0.046). Knockout of CXCR4 gene could significantly impair the capacity of cholesterol efflux (P < 0.01). These findings strongly suggest that CXCR4 polymorphisms might contribute to CAD susceptibility, and the exact biological mechanism awaits further research.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23491